PERSONAL INJURY LAW for OVER 45 YEARS! We Have Won Over 98% of Our Cases*

Why Is Non-Hodgkins Lymphoma a High Risk to Develop in the Body in Relation to Roundup Exposures?

Why Is Non-Hodgkins Lymphoma a High Risk to Develop in the Body in Relation to Roundup Exposures?

Occupational Exposure to Roundup Can Trigger Non-Hodgkin’s Lymphoma in Humans

If you are exposed to Roundup chemicals you can develop non-Hodgkin’s lymphoma in your body as a result of the exposure. Overall, the glyphosates in Roundup formulas are hazardous to human health, and can increase your risk of developing lymphoma to a high degree, even after low measurements of exposures.1

Any time that you are exposed to pesticides, herbicides and other harsh chemicals you are going to significantly increase your risk of developing cancer in your body because of the exposure to these dangerous compounds. If this situation applies to you, call us at Walch law to talk to a Los Angeles Roundup lawyer at 866-INJURY2 or 866-465-8792 today.

What Exactly Is Non-Hodgkin Lymphoma in Relation to a Roundup Cancer?

A non-Hodgkin lymphoma is a group of lymphoid malignant cells that are cancerous in the body. There are many subtypes of these types of cancers that have a variety of different:2

  • Distinct clinical features
  • Prognosis
  • Diagnosis
  • Treatment plans
  • Treatment responses
  • Aggressiveness of disease
  • Treatment modalities
  • Therapies
  • Treatment for relapse

If you have questions regarding the worth, value or settlement procedures related to a Roundup cancer lawsuit, you need to call our law office today to talk about your concerns. We are available to take your call at Walch law, and you can call us at 866-INJURY2 or 866-465-8792.

References

1Fritschi, L., Benke, G., Hughes, A. M., Kricker, A., Turner, J., Vajdic, C. M., Grulich, A., Milliken, S., Kaldor, J., & Armstrong, B. K. (2005). Occupational exposure to pesticides and risk of non-Hodgkin’s lymphoma. American Journal Of Epidemiology162(9), 849–857. https://doi.org/10.1093/aje/kwi292

2Liu, L., Jin, F., & Fan, H. (2024). Metabolic tumor volume and the survival of patients with Non-Hodgkin lymphoma treated with chimeric antigen receptor T cell therapy: a meta-analysis. Frontiers in immunology15, 1433012. https://doi.org/10.3389/fimmu.2024.1433012

Contact Information